Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
03/21/2013 | WO2013003649A3 Wap domain fusion polypeptides and methods of use thereof |
03/21/2013 | WO2012173846A3 Peptidomimetic macrocycles |
03/21/2013 | WO2012103496A3 Expression of soluble viral fusion glycoproteins in mammalian cells |
03/21/2013 | US20130074201 Cancer-specific genetic rearrangements |
03/21/2013 | US20130072666 Antibody Complexes and Methods for Immunolabeling |
03/21/2013 | US20130072657 CELL GROWTH INHIBITOR DERIVED FROM p16INK4a AND METHOD OF SYNTHESIZING THE SAME |
03/21/2013 | US20130071951 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
03/21/2013 | US20130071410 Human CGRP Receptor Binding Proteins |
03/21/2013 | US20130071379 1b20 pcsk9 antagonists |
03/21/2013 | CA2848204A1 Glucagon-like peptide-2 compositions and methods of making and using same |
03/20/2013 | EP2570482A1 Gene encoding lignan methyltransferase, and use thereof |
03/20/2013 | EP2569013A2 Humanized and chimeric monoclonal antibodies to cd47 |
03/20/2013 | EP2569012A2 Anti-fgfr2 antibodies |
03/20/2013 | EP2569003A2 Parathyroid hormone analogs and uses thereof |
03/20/2013 | EP1423191B1 Solid compositions for selective adsorption from complex mixtures |
03/20/2013 | CN1571834B Cell therapy method for the treatment of tumors |
03/20/2013 | CN102985542A Method for producing pentameric CRP, pentameric CRP-producing transgenic silkworm and method for constructing same, DNA encoding canine monomeric CRP and expression vector containing the DNA |
03/20/2013 | CN102985541A Host, transformant, method for producing the transformant, and method for producing heterogeneous protein containing O-glycoside type sugar chain |
03/20/2013 | CN102978270A Preparation method for tussah silk glutin powder |
03/20/2013 | CN102978269A Method for preparing soybean peptides from carrier-free immobilized enzyme |
03/20/2013 | CN102978268A Method for preparing egg albumin polypeptide from egg albumin powder by enzymic method |
03/20/2013 | CN102978267A Method for preparing glutathione through enzyme method |
03/20/2013 | CN102978214A Chicken-gamma-interferon gene sequence, recombinant engineering bacteria and application thereof |
03/20/2013 | CN102977844A Modified vegetable protein adhesive and preparation method thereof |
03/20/2013 | CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production |
03/20/2013 | CN102977187A Bacteriocin inducer peptides |
03/20/2013 | CN102389071B Donkey-hide gelatin raw powder and its preparation method |
03/20/2013 | CN102250917B Method for preparing IL28B and special recombinant bacterium |
03/20/2013 | CN102242073B Method for preparing daptomycin by fermentation |
03/20/2013 | CN102199486B Method for integrated utilization for sunflower seeds |
03/20/2013 | CN101928335B Fungus antitumor polypeptide nucleotide sequence, and preparation method and applications thereof |
03/20/2013 | CN101522715B Monoclonal antibody to soluble lox-1 |
03/20/2013 | CN101420969B Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function |
03/20/2013 | CN101230345B Multiple promoters and their use for gene expression |
03/19/2013 | US8399657 Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
03/19/2013 | US8399651 Nucleic acids encoding GAS57 mutant antigens |
03/19/2013 | US8399647 Alpha5-beta1 antibodies and their uses |
03/19/2013 | US8399646 Isolated nucleic acid encoding an antibody which specifically binds to PCSK9 and a host cell that produces the antibody |
03/19/2013 | US8399630 Engineered anti-IL-13 antibodies, compositions, methods and uses |
03/19/2013 | US8399629 Antibody modulators of hepatocyte growth factor activator |
03/19/2013 | US8399628 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof |
03/19/2013 | US8399625 Acceptor framework for CDR grafting |
03/19/2013 | US8399624 Acceptor framework for CDR grafting |
03/19/2013 | US8399623 Human antibodies that bind mesothelin, and uses thereof |
03/19/2013 | US8399618 Immunoglobulin insertions, deletions, and substitutions |
03/19/2013 | US8399232 Enzyme associated with equol synthesis |
03/19/2013 | US8399220 Antibacterial compositions |
03/19/2013 | US8399219 Protease activatable interferon alpha proprotein |
03/19/2013 | US8399218 Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes |
03/19/2013 | US8399211 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
03/19/2013 | US8399202 Peptides for development of diagnostic and therapeutic agents and methods of using same |
03/19/2013 | US8398999 Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870 |
03/19/2013 | US8398984 Removal promoters and inhibitor for apoptosis cells in vivo |
03/19/2013 | US8398982 Compositions and methods for the diagnosis and treatment of tumor |
03/19/2013 | US8398980 Subtypes of humanized antibody against interleuken-6 receptor |
03/19/2013 | US8398977 Rage fusion proteins |
03/19/2013 | CA2551905C Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof |
03/19/2013 | CA2471702C Human monoclonal antibodies against cd30 |
03/19/2013 | CA2452767C Genetic recombinant ecarin and process for preparing the same |
03/19/2013 | CA2434364C Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
03/19/2013 | CA2367901C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
03/19/2013 | CA2354638C Expression of secreted human alpha-fetoprotein in transgenic animals |
03/19/2013 | CA2311647C Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
03/19/2013 | CA1341635C Insect-resistant plants |
03/14/2013 | WO2013036926A2 Identification of specific apolipoprotein epitopes on circulating atherogenic low-density lipoprotein |
03/14/2013 | WO2013036755A1 Etv1 antibodies and uses thereof |
03/14/2013 | WO2013036445A1 Methods for processing coagulation factors |
03/14/2013 | WO2013036429A2 Single-container manufacturing of biological product |
03/14/2013 | WO2013035208A1 ANTIBODY AGAINST MUTANT α-ACTININ-4 |
03/14/2013 | WO2012170782A3 Production of post-translationally hydroxylated recombinant proteins in bacteria |
03/14/2013 | US20130066052 Ucp4 |
03/14/2013 | US20130066051 Fusion polypeptide against eb virus-induced tumor and colicin ia mutant |
03/14/2013 | US20130066046 General Method for Generating Ultra-High Affinity Binding Proteins |
03/14/2013 | US20130065829 Peptides and supported peptides for treating skin diseases |
03/14/2013 | US20130065810 Novel Fungal Protease and Use Thereof |
03/14/2013 | US20130065278 Production of proteins and polypeptides |
03/14/2013 | US20130065277 Sequence dependent aggregation |
03/14/2013 | US20130065276 Compositions and methods of treating disease with fgfr fusion proteins |
03/14/2013 | US20130065275 Serum-free mammalian cell culture medium, and uses thereof |
03/14/2013 | US20130065274 Recombinant Prokaryotes and Use Thereof for Production of O-Glycosylated Proteins |
03/14/2013 | US20130065273 Engineered E2 For Increasing The Content Of Free LYS11-Linked Ubiquitin |
03/14/2013 | US20130065272 Synthesis of Site Specifically-Linked Ubiquitin |
03/14/2013 | US20130065271 Host Cells and Culture Methods |
03/14/2013 | US20130065270 Non-Recombinant Saccharomyces Strains that Grow on Xylose |
03/14/2013 | US20130065254 Novel epigenetic mechanisms related to dna damage and aging |
03/14/2013 | US20130064853 Parasite vaccine |
03/14/2013 | US20130064851 Inactivated staphylococcal whole-cell vaccine |
03/14/2013 | US20130064844 Non-splicing variants of gp350/220 |
03/14/2013 | US20130064830 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
03/14/2013 | US20130064829 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization |
03/14/2013 | US20130064827 Il-17 homologous polypeptides and thereapeutic uses thereof |
03/14/2013 | US20130064817 Engineered anti-il-23r antibodies |
03/14/2013 | US20130064813 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof |
03/14/2013 | US20130064790 Peptides with the capacity to bind to interleukin-10 (il-10) |
03/14/2013 | US20130064788 Il-17 family cytokine compositions and uses |
03/14/2013 | US20130064761 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof |
03/14/2013 | US20130064760 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody |
03/14/2013 | CA2848122A1 Single-container manufacturing of biological product |
03/14/2013 | CA2847818A1 Methods for processing coagulation factors |
03/13/2013 | EP2566972A1 Compositions for linking zinc finger modules |